Home   /  Find a Trial  /  See All TrialsHELP /  AYUDA /  求助 : (415) 476-5777 | Click to print page Print
 

See All Trials

QuickViews

Match by Tumor Type:

Newly Diagnosed (Stage I-III)
Biomarker status:
 Hormone-positive (ER+ and/or PR+)
 HER2-positive (HER2+)
 Triple negative (ER-/PR-/HER2-)
Inflammatory Breast Cancer
Biomarker status:
 Hormone-positive (ER+ and/or PR+)
 HER2-positive (HER2+)
 Triple negative (ER-/PR-/HER2-)

View by Trial Type:

Treatment:

 

Non-Treatment:

see All Trials

Sort by zip code:  

 

Share

Facebook
Twitter
Twitter

 
Young Survivors

Reproductive Health Survivorship Care Plan for Young Survivors

Intervening on Reproductive Health in Young Breast Cancer Survivors (NCT02667626)

Summary

Young breast cancer survivors frequently have concerns about fertility, birth control, and sexual function. Researchers have developed a survivorship care plan for young survivors that addresses these reproductive health issues. This study is comparing the effectiveness of two different survivorship care plans for young survivors. As part of the study, participants will discuss reproductive health issues with the healthcare provider of their choice. To be eligible, a woman must have been diagnosed with breast cancer within the past five years and must have been age 45 or younger at the time of her diagnosis.
This is a Phase III trial

  • Participation Time3 online questionnaires over 6 months
  • No Visits Required for this TrialNo travel required 
What's Involved    Contact information: Call BCT at (415) 476-3793

Skills Workshop to Improve Memory & Thinking in Breast (and Other) Cancer Survivors

Behavioral and Neural Indices of Cognitive Rehabilitation in Women's Cancer: A Pilot Study (NCT01641068)

Summary

Thinking abilities, concentration, mood and quality of life can be affected by cancer and its treatments. This study is investigating the benefits of a memory and thinking skills workshop designed for breast and other cancer survivors. To be eligible for the study, survivors must have been treated with chemotherapy. Participants will be randomly assigned to either the skills workshop or a workshop on the brain and cognition. After the study is completed, the individuals who took part in the brain and cognition education workshop can take part in the memory and thinking skills workshop. To be eligible, participants must be able to attend a minimum of 3 testing sessions in Seattle, WA.

  • Participation TimeVisits weekly over 2 months
  • Participating research sites
    Research sites:
    Call BCT: (415) 476-3793
What's Involved    Contact information: Call BCT at (415) 476-3793

Improving Quality of Life Among Latina, Spanish-Speaking Breast Cancer Survivors

Developing an Intervention to Reduce Stress and Improve Quality of Life in Underserved Urban Latina Breast Cancer Survivors (NCT02521961)

Summary

Taking part in a support group may help Latina breast cancer survivors reduce distress and improve their health-related quality of life. This study is evaluating the effectiveness of a support group developed specifically for Latina breast cancer survivors. The group will address topics such as stress management and emotional coping strategies, nutrition and physical activity, sexuality and body image, medical advocacy and self-care, and social support. To be eligible, participants must be a Spanish-speaking Latina and a current resident of King, Snohomish, or Pierce counties in Washington State.

  • Participation TimeVisits weekly
  • Participating research sites
    Research sites:
    Call BCT: (415) 476-3793
What's Involved    Contact information: Call BCT at (415) 476-3793

Breast Cancer in Women Diagnosed Before Age 40

Identification of Novel Genetic Risk Factors That Contribute to the Risk for Breast Cancer (NCT00276120)

Summary

Breast cancer is the leading cause of cancer deaths in women 20-39 years of age. The goal of this trial is to identify the genetic factors that distinguish breast cancer in younger women compared to older women. The researchers hope that identifying these genetic factors will lead to new treatments for younger women who have been diagnosed with breast cancer or who are at high-risk for developing the disease. All women who were diagnosed with breast cancer at age 40 or younger (regardless of current age) are eligible to participate. Because all study-related materials will be mailed, participants can live anywhere in the U.S.

  • Participation TimeBlood sample and questionnaire by mail
  • No Visits Required for this TrialNo travel required 
What's Involved    Contact information

Sexual and Reproductive Health Study

Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma (NCT01788839)

Summary

Cancer and its treatment may affect sexual and reproductive health. To help researchers learn more about the problems women face, participants in this study will complete questionnaires on sexuality and pregnancy before, during, and after cancer treatment. The information will be used to help doctors identify which women are most likely to have early menopause or develop sexual problems during cancer therapy, or have difficulty getting pregnant after cancer treatment. To be eligible for this study a woman must be age 50 or younger, newly diagnosed with breast cancer, and planning on having, or within one month of starting, chemotherapy.

What's Involved    Contact information

The Young Women's Breast Cancer Study

Helping Ourselves, Helping Others: The Young Women's Breast Cancer Study (NCT01468246)

Summary

Young women with breast cancer have unique needs and concerns. The goal of this study is to follow a large group of young women with breast cancer over time to learn more about the types of tumors they develop, the treatments they have, the side effects they experience, and the psychosocial concerns they face. The researchers are also interested in seeing if there is a relationship between tumor biology and patient outcome. To be eligible, participants must have been diagnosed with breast cancer at age 40 or younger.

What's Involved    Contact information

Measuring Breast Density in Premenopausal Breast Cancer Patients on Tamoxifen

Development of a Quantitative Tissue Optical Index of Breast Density (NCT01773551)

Summary

Some studies have suggested that premenopausal breast cancer patients whose breasts become less dense (as measured by a mammogram) while they are on tamoxifen are less likely to have a recurrence than women on tamoxifen whose breast density does not change. Researchers have developed a new tool called diffuse optical spectroscopic imaging that uses light to measure tissue thickness. This study is looking at whether this new tool can be used to measure changes in breast density. To be eligible, a woman must be premenopausal and taking tamoxifen to treat stage I - III breast cancer.

What's Involved    Contact information

Ovarian Function After DCIS and Breast Cancer

Predictors of Ovarian Insufficiency Through Serial Exams in Young Breast Cancer Patients (POISE Study) (NCT01197456)

Summary

Premenopausal women may face issues related to having children as they undergo breast cancer care, and these concerns may influence their treatment choices. Tools that can accurately predict how treatment may affect ovarian function could help women and their doctors make choices that take into account the potential impact on fertility. The goal of this study is to identify pre-chemotherapy hormonal, genetic, and ovarian imaging markers that can predict whether a woman's ovaries are likely to continue to function at the end of her cancer treatments. Participants will be followed from the time of diagnosis to five years after treatment.

What's Involved    Contact information

Immune System Response to Breast Cancer in Women Under Age 50

A Translational Study of the Interactions Between Prior Pregnancy and the Biologic Subtype of Breast Cancer in Defining the Cancer: Host Immunologic Interaction (NCT01503190)

Summary

Researchers are interested in learning more about the role the immune system plays in cancer. This study is looking specifically at the immune system in women with breast cancer who are under age 50. The researchers will look to see if differences in their immune system correspond to different types of tumors including tumors that develop during or after a pregnancy. The investigators may go on to use some of the breast cancer tissue collected in this study to create models that could be used to develop and test new drug treatments.

What's Involved    Contact information